Marqus-Torrejn MWC, Southgate B, Alfazema N, Clements MP, Garcia-Diaz C, Blin C, Arranz-Emparan N, Fraser J, Gammoh N, Parrinello S, Pollard SM (2021) LRIG1 is a gatekeeper to exit from quiescence in adult neural stem cells
Proper placement and cannula patency were verified via 5-thio-D-glucose (210 g)-induced hyperglycemia, as previously described (Mietlicki-Baase, Liberini et al
Rege, J
This will be dependent on each patients tolerance to the medication
Mismatched cells can lead to uneven charging and risk of over-discharge or swelling
The predominantly hepatic metabolism of orforglipron does, however, raise the question of whether dose adjustment is needed in hepatic impairment, an issue that was addressed in dedicated hepatic impairment studies during the clinical development program